Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by juniper88on Jun 12, 2020 11:21am
70 Views
Post# 31143424

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Salvage therapy new paper

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Salvage therapy new paperYou sure write a lot but it is all nonsense.  How did you know you bought at a great price if you did not now what the company is worth?? I think you should take your 9 cents/share profit and move on...

Victura wrote: Haha, and out come the tin foil hats again.  Have you considered the possibility that because I bought at a great price that I don't have the same needs as people who bought it higher?  I'm up on my investment right now, at this very moment.  I'm not someone who bought at $6 and took a bath and by necessity has to believe it'll go back there again.  My needs for what the outcome has to be here, are different than most.  If the stock went to $2.50 for instance (and please for the love of god push it up!), I'd be dancing in the streets.  That wouldn't be enough for most of the people talking here I'd wager.  I'm coming at this from a different perspective because I can see what the long term holders of this stock have been through, and I have the luxury of not having suffered through any of it and bought low.  If you really desperately need this stock to go a lot higher just to be okay, I'm sorry about that and I don't ask these questions or lend my analysis to hurt you.  But nothing about that invalidates my thoughts or questions, and if you have real data or analysis or thoughts to share that refutes my view point I WANT IT!  That would only make me feel better.  Don't get mad, help me understand how you value the stock with real financial acumen.  Best wishes.


Bullboard Posts